Anding, Michael C.

HRN: 28-93-11  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
CEFTRIAXONE 1G (VIAL)
04/29/2026
05/06/2026
IV
2g
OD
UROSEPSIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: